Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults

NCT05258669 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
400
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ocugen